Allogene Therapeutics
Price & Volume
Stats
See more52W Range | $0.98-$4.46 |
Market Cap | $617.8M |
Shares Short | 63M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | -$131.9M |
Diluted EPS | -$0.77 |
News
See moreYahoo Finance • 28 days ago
Why Avalo Therapeutics, Inc. (AVTX) Is Among the Best Low Priced Stocks to Get Rich in 2026
Yahoo Finance • last month
How Allogene Therapeutics (ALLO) Is Expanding Its Off-the-Shelf CAR T Platform Across Cancer and Autoimmune Disease
Yahoo Finance • last month
Allogene Therapeutics, Inc. (ALLO) A Top Penny Stock to Buy on Robust CAR T-Cell Portfolio
Yahoo Finance • 2 months ago
Allogene Therapeutics Announces Participation in Upcoming Investor Conferences
About
CEO | Dr. Zachary J. Roberts M.D., Ph.D. |
CFO | Mr. Geoffrey M. Parker |
Address | 210 East Grand Avenue, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 150 |